Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
EPA CPDat observed this chemical in 0 composition records across product categories including unclassified products.
Concern score
The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 45/100 (moderate) · high confidence.
Prevalence of DEXTRATES in our catalog (epa_cpdat).
Brands
1
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 0 composition records across product categories including unclassified products.
US
FDA
Route: ORAL; Dosage form: POWDER; Maximum daily exposure: 2567 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 437 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 6398 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 437 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 594 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 311 mg
US
FDA
Route: ORAL; Dosage form: TROCHE; Maximum daily exposure: 4505 mg
US
FDA
Route: TRANSMUCOSAL; Dosage form: LOZENGE; Maximum daily exposure: 7360 mg
US
FDA
openFDA substance registry classifies this ingredient as mixture.